by Gabi Schaller | Dec 20, 2022 | News
December 20, 2022 – VIENNA, AUSTRIA: Ribbon Biolabs, the DNA synthesis company, today announced the successful implementation of their innovative InfiniSynth™ platform for the automated assembly of sequence-agnostic and long DNA. Ribbon Biolabs achieved this...
by Gabi Schaller | Aug 16, 2022 | Allgemein, News
We are thrilled to be shortlisted as one of 25 winners of the Falling Walls Venture 2022! Falling Walls Venture is a global platform for the most promising science start-ups who have successfully turned science into business, proving how entrepreneurial solutions can...
by Gabi Schaller | Jul 19, 2022 | Allgemein, News
We are very proud to announce the issuance of our first U.S. patent (US 11352619 B2) covering our novel method for synthesizing double stranded DNA using a diverse library of oligonucleotides. The patent enables us to proprietarily exploit our differentiating...
by Gabi Schaller | Jun 30, 2022 | Allgemein, News
Ribbon Biolabs is very honoured to be one of 15 innovative Start-ups awarded as ‘Born Global Champions’. The award is presented annually by the Austrian Economic Chamber to young companies that have succeeded in positioning innovative products and services...
by Gabi Schaller | Apr 12, 2022 | News
After a couple of years of online meetings, we’ll join this year’s Global Synthetic Biology Conference on April 12-13 LIVE in Oakland! The conference is hosted by Built with Biology (formerly SynBioBeta), an innovation network for biological engineers,...
by Gabi Schaller | Jan 31, 2022 | News
January 31, 2022, VIENNA, AUSTRIA: Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from...
